Thiazolidinedione use and the risk of fractures
- PMID: 19364797
- PMCID: PMC2665963
- DOI: 10.1503/cmaj.1090005
Thiazolidinedione use and the risk of fractures
Comment on
-
Thiazolidinediones: do harms outweigh benefits?CMAJ. 2009 Jan 6;180(1):16-7. doi: 10.1503/cmaj.081713. Epub 2008 Dec 10. CMAJ. 2009. PMID: 19073650 Free PMC article. No abstract available.
-
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.CMAJ. 2009 Jan 6;180(1):32-9. doi: 10.1503/cmaj.080486. Epub 2008 Dec 10. CMAJ. 2009. PMID: 19073651 Free PMC article.
References
-
- Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New Engl J Med. 2006;355:2427–43. - PubMed
-
- Dillon JA. Increased incidence of fractures in female patients who received long-term treatment with AVANDIA (rosiglitazone maleate) tablets for type 2 diabetes mellitus. Mississauga (ON): GlaxoSmithKline Inc; 2007. [Dear Health Care Provider letter]
-
- GlaxoSmithKline Inc. Association between long-term treatment with AVANDIA (rosiglitazone maleate) tablets for type 2 diabetes mellitus and fracture in women. Mississauga (ON): GlaxoSmithKline Inc; 2007. [Dear Patient letter]
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical